Skip to main content
. 2021 Jul 29;107(7):1608–1618. doi: 10.3324/haematol.2021.278853

Table 3.

Primary and secondary outcomes: rates of complete response, overall response, and survival for all three cohorts, including the subset of Hodgkin lymphoma patients in the exploratory cohort.

graphic file with name 1071608.tab3.jpg